Skip to main content

Table 5 Baseline participant characteristics

From: Mindfulness-based stress reduction for people with multiple sclerosis – a feasibility randomised controlled trial

  Intervention Control Significance p
Mean age in years (standard deviation - SD) 43.6 (10.7) 46.3 (11.1) 0.37
Sex Female 23 (92%) Female 22 (88%) 1.00
Ethnicity White British 25 (100%) White British 25 (100%) 1.00
MS phenotype
RRMS – relapsing remitting; SPMS – secondary progressive; PPMS – primary progressive
RRMS 22 (88%) RRMS 18 (72%) 0.74
SPMS 1 (4%) SPMS 7 (28%)
PPMS 2 (8%)
Deprivation 5.0 (2.8) 5.4 (2.6) 0.64
Education – highest level Secondary school 3 (12%) Secondary school 5 (20%) 0.73
College 7 (28%) College 7 (28%)
University 15 (60%) University 13 (52%)
Employment Full time 4 (16%) Full time 7 (28%) 0.39
Part time 3 (12%) Part time 6 (24%)
Unemployed 6 (24%) Unemployed 7 (28%)
Retired 5 (20%) Retired 3 (12%)
Other 7 (28%) Other 2 (8%)
Living arrangement Lives alone 6 (24%) Lives alone 3 (12%) 0.54
With partner 9 (36%) With partner 10 (40%)
With family/friends 10 (40%) With family/friends 12 (48%)
EDSS 4.5 (1.8) 4.3 (1.7) 0.64
Mean disease duration in years (SD) 8.9 (8.5) 9.6 (9.4) 0.79
Mean total comorbidity count (SD) 2.5 (2.2) 2.3 (1.9) 0.68
Mean mental health comorbidity count (SD) 0.8 (0.83) 0.7 (0.8) 0.73
• Comorbid anxiety 11 (44%) 8 (32%) 0.12
• Comorbid depression 9 (36%) 11 (44%) 0.29
Mean physical health comorbidity count (SD) 1.8 (1.5) 1.6 (1.5) 0.71
Using analgesic drugs 19 (76%) 17 (68%) 0.75
Using disease modifying drugs 14 (56%) 12 (48%) 0.78
Using antidepressant drugs 12 (48%) 11 (44%) 1.00
Previous meditation/yoga experience 17 (68%) 10 (40%) 0.04
  1. *Statistically significant difference